Bevasiranib sodium
Product Specifications
CAS Number
849758-52-7
Target
Others, VEGFR
Related Pathways
Others, Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
Bevasiranib sodium, an siRNA compound, targets and silences the genes responsible for producing vascular endothelial growth factor (VEGF) . The suppression of VEGF, a critical factor in the development of choroidal neo-vascularization (CNV), aims to thwart the progression to wet age-related macular degeneration (wet AMD) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
I8600-15A-ML490 100 µL
IRAK 2 (IL-1 Receptor-associated Kinase) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
orb2920970-01 20 µg
Recombinant Brevibacillus brevis UPF0756 membrane protein BBR47_12340 (BBR47_12340)
Sign In for Pricing
View Details orb2920970-02 100 µg
Recombinant Brevibacillus brevis UPF0756 membrane protein BBR47_12340 (BBR47_12340)
Sign In for Pricing
View Details